Physician profile
Stephanie P Su
NPI 1447323795
$20,413.44
in general payments reported to CMS, 2019-2025
19 companies · $586 in 2025
The $586 reported for 2025 was more than what 81% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $309 · 2020: $541 · 2021: $397 · 2022: $18K · 2023: $603 · 2024: $249 · 2025: $586.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,087 · Gift: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.33 |
| Gift | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clerio Vision, INC | $17,517.50 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $528.14 | 2019-2025 | |
| Visionary Optics LLC | $350.00 | 2023 | |
| Alcon Vision LLC | $273.91 | 2019-2025 | Precision 1, Rocklatan, Total30 |
| Coopervision INC. | $271.78 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $228.97 | 2022-2024 | Infuse, Miebo, Xiidra |
| Biotissue Holdings INC. | $223.50 | 2019-2025 | |
| Sight Sciences, INC. | $209.12 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $159.33 | 2020-2025 | Cequa |
| Dompe US, INC. | $151.38 | 2024-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $117.21 | 2019-2021 | |
| Lkc Technologies, INC. | $110.44 | 2022 | |
| Oyster Point Pharma, INC. | $67.49 | 2025 | Ryzumvi, Tyrvaya |
| Maculogix, INC. | $47.13 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $42.80 | 2024 | Xdemvy |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Shire North American Group INC | $38.34 | 2019 | |
| Thea Pharma INC. | $20.36 | 2025 | Iyuzeh |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Su listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.